In this respiratory disease roundup, researchers report on the efficacy of nirmatrelvir-ritonavir for treating Long COVID, the CDC updates recommendations on “triple threat” vaccines for respiratory virus...
Although more patients are seeking pain relief in primary care settings, practitioners may not have the experience in managing and treating patients with complex pain situations or may not be familiar with...
In a recent retrospective cohort study, researchers examined changes in the medication regimens of patients with type 2 diabetes following the initiation of second-line therapy.
The once-monthly RNA interference injection medication received FDA approval based on results from the phase II PHYOX2 clinical trial and phase III PHYOX3 extension study.
Researchers evaluated whether patients with atherosclerotic cardiovascular disease (ASCVD) are utilizing high-intensity statins in their routine care of the disease.
Researchers conducted a retrospective analysis of 469 patients with HR+/HER2- metastatic breast cancer and cardiovascular diseases treated with palbociclib plus aromatase inhibitors or aromatase inhibitors...
The results of a recent study presented at the 2023 Hematology/Oncology Pharmacy Association annual conference suggest health care providers should be vigilant about the overutilization of potentially...
